Israeli stem cell therapy company Gamida Cell Ltd. has announced success in the Phase III clinical trial of its treatment for leukemia and lymphoma StemEx. The results show a mortality rate which is 35.5 percent lower for people treated with StemEx, as opposed to people who were not.
Related posts
Top European Carmakers To Include Israeli Chipset In New Vehicles
September 18, 2024
Sheba Named As One Of World's Top 10 Smart Hospitals
September 18, 2024
New AI-Powered Robot Specializes In Picking Citrus Fruit
September 17, 2024
Researchers Develop New Early Identification For Parkinson’s
September 16, 2024
Facebook comments